Indium In-111 chloride is a diagnostic radiopharmaceutical agent used for radiolabelling monoclonal antibodies in preparations used for in vivo diagnostic imaging procedures. It is supplied as a sterile, pyrogen-free solution of Indium ("'In) Chloride in O.04M HCI.
- Mechanism
- Curator reviewed
Indium In-111 Chloride is a radioactive tracer for labeling monoclonal antibodies in certain preparations such as OncoScint, ProstaScint and Zevalin. Its mechanism of action is related to the final product and not specific to Indium In-111 Chloride alone
- Primary indication
- Indium In-111 Chloride is indicated for radio labeling of monoclonal antibodies in preparations used for in vivo diagnostic imaging procedures.Curator reviewed · 4 structured indications
- Formula / weight
- Cl3In · 217.26 g/mol (avg)
- First approval
- United States, 1992
- Also known as
- 111indium trichloride · Indium chloride In-111 · Indium In 111 chloride · Indium In 111m chloride · Indium In-111m chloride
- Brand names
Resolves to
Clinical / RWD
Structure
InChIKey
PSCMQHVBLHHWTO-FZTWWWDYSA-KSMILESCl[111In](Cl)ClTargets
What you can answer from here — as of July 06, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Indium In-111 chloride, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account